Stephen DuBois
@Camber Capital Management Lp
Latest period2024 - Q3ReportedManaged Assets$3.149BTotal holdings33
Assets growth rate-12.86%Assets growth rate (2-Q avg)-12.15%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Camber Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 33 positions.
Assets under management
The assets under management (AUM) of Camber Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.149B in assets, with a quarterly growth rate of -12.86% and a 2-quarter average growth rate of -12.15%. The portfolio is managed by Stephen DuBois, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ASNDAscendis Pharma A S
| 3.32% | $104.517M 700,000 shares@ $149.31 avg price | New Position |
SRPTSarepta Therapeutics Inc
| 3.08% | $96.79M 775,000 shares@ $124.9 avg price | Increased 416.67% |
BKDBrookdale Sr Living Inc
| 3.01% | $94.619M 13.935M shares@ $6.8 avg price | Decreased -10.09% |
CVSCvs Health Corp
| 3% | $94.32M 1.5M shares@ $62.88 avg price | |
SEMSelect Med Hldgs Corp
| 2.36% | $74.099M 2.125M shares@ $34.88 avg price | Decreased -16.66% |
QGENQiagen Nv
| 2.18% | $68.355M 1.5M shares@ $45.57 avg price | |
HUMHumana Inc
| 2.02% | $63.348M 200,000 shares@ $316.74 avg price | Decreased -50% |
DNLIDenali Therapeutics Inc
| 1.86% | $58.26M 2M shares@ $29.13 avg price | |
CONConcentra Group Holdings Par
| 1.41% | $44.161M 1.975M shares@ $22.36 avg price | New Position |
ZIMVZimvie Inc
| 1.38% | $43.246M 2.725M shares@ $15.88 avg price | Decreased -16.15% |